相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma
Francesca Bonello et al.
CANCERS (2020)
Brief communication: Distribution of bone marrow cell subsets and hemodilution in patients with acute leukemia
Georgina Gener et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)
B cells, plasma cells and antibody repertoires in the tumour microenvironment
George Sharonov et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma
Veronica Gonzalez-Calle et al.
HAEMATOLOGICA (2017)
Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials
Juan-Jose Lahuerta et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
A simple flow-cytometry method to evaluate peripheral blood contamination of bone marrow aspirates
Jose Antonio Delgado et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2017)
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
J. Flores-Montero et al.
LEUKEMIA (2017)
Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma
Veronica Gonzalez-Calle et al.
HAEMATOLOGICA (2017)
Multiple myeloma
Shaji K. Kumar et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Understanding the reconstitution of the B-cell compartment in bone marrow and blood after treatment for B-cell precursor acute lymphoblastic leukaemia
Prisca M. J. Theunissen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT
Christine M. Ho et al.
BLOOD ADVANCES (2017)
Multiple myeloma patients in long-term complete response after autologous stem cell transplantation express a particular immune signature with potential prognostic implication
A. Arteche-Lopez et al.
BONE MARROW TRANSPLANTATION (2017)
Consensus Guidelines on Plasma Cell Myeloma Minimal Residual Disease Analysis and Reporting
Maria Arroz et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2016)
Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives
S. Lonial et al.
LEUKEMIA (2016)
Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients
Bruno Paiva et al.
BLOOD (2016)
The Emerging Role of B Cells in Tumor Immunity
Peiling Tsou et al.
CANCER RESEARCH (2016)
Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer
David R. Kroeger et al.
CLINICAL CANCER RESEARCH (2016)
Immune Therapies in Multiple Myeloma
Shaji K. Kumar et al.
CLINICAL CANCER RESEARCH (2016)
Infection risk with immunomodulatory and proteasome inhibitor-based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysis
Benjamin W. Teh et al.
EUROPEAN JOURNAL OF CANCER (2016)
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar et al.
LANCET ONCOLOGY (2016)
Multiple Myeloma: Diagnosis and Treatment
S. Vincent Rajkumar et al.
MAYO CLINIC PROCEEDINGS (2016)
Immunoglobulin Recovery after ASCT for Patients with Multiple Myeloma: Impact on Overall Survival and Progression-Free Survival
Victor Jimenez-Zepeda et al.
BLOOD (2016)
Treatment for patients with newly diagnosed multiple myeloma in 2015
Maria-Victoria Mateos et al.
BLOOD REVIEWS (2015)
Lymphocyte Subset Recovery and Outcome after Autologous Hematopoietic Stem Cell Transplantation for Plasma Cell Myeloma
Jessica Rueff et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Changing treatment paradigms for patients with plasma cell myeloma: Impact upon immune determinants of infection
Benjamin W. Teh et al.
BLOOD REVIEWS (2014)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma
Sarah M. Tete et al.
FRONTIERS IN IMMUNOLOGY (2014)
Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry
Roberto J. Pessoa de Magalhaes et al.
HAEMATOLOGICA (2013)
Natural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem cell transplantation: long-term results from a single institution
Natalia Tovar et al.
HAEMATOLOGICA (2013)
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
T. Kalina et al.
LEUKEMIA (2012)
Can we change the disease biology of multiple myeloma?
Ivan Borrello
LEUKEMIA RESEARCH (2012)
Excess bone marrow B-cells in patients with multiple myeloma achieving complete remission following autologous stem cell transplantation is a biomarker for improved survival
Elizabeth Byrne et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma
B. Paiva et al.
LEUKEMIA (2011)
Human Peripheral Blood B-Cell Compartments: A Crossroad in B-Cell Traffic
M. Perez-Andres et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2010)
被撤回的出版物: Systemic signals regulate ageing and rejuvenation of blood stem cell niches (Retracted article. See vol. 467, pg. 872, 2010)
Shane R. Mayack et al.
NATURE (2010)
Flow Cytometric Immunophenotyping and Minimal Residual Disease Analysis in Multiple Myeloma
Ritu Gupta et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Infections in Patients with Multiple Myeloma in the Era of High-Dose Therapy and Novel Agents
Marcio Nucci et al.
CLINICAL INFECTIOUS DISEASES (2009)
Flow Cytometric Differential of Leukocyte Populations in Normal Bone Marrow: Influence of Peripheral Blood Contamination
R. A. Brooimans et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2009)
Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients
Bruno Paiva et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma
R. A. Kyle et al.
LEUKEMIA (2009)
Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
Andy C. Rawstron et al.
HAEMATOLOGICA (2008)
CD44 and CD27 delineate B-precursor stages with different recombination status and with an uneven distribution in nonmalignant and malignant hematopoiesis
M. Vaskova et al.
TISSUE ANTIGENS (2008)
Competence and competition:: the challenge of becoming a long-lived plasma cell
Andreas Radbruch et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Expression of CD27-CD70 on early B cell progenitors in the bone marrow:: Implication for diagnosis and therapy of childhood ALL
A Nilsson et al.
EXPERIMENTAL HEMATOLOGY (2005)
Age-related changes in lymphocyte development and function
PJ Linton et al.
NATURE IMMUNOLOGY (2004)
Cellular niches controlling B lymphocyte behavior within bone marrow during development
K Tokoyoda et al.
IMMUNITY (2004)
Drug therapy: Multiple myeloma
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome
JF San Miguel et al.
BLOOD (2002)
分享论文
